Thiamine is one of several essential cofactors for ATP generation. Its deficiency, like in beriberi and in the Wernicke-Korsakoff syndrome, has been studied for many decades. However, its mechanism of action is still not completely understood at the cellular and molecular levels. Since it acts as a coenzyme for dehydrogenases of pyruvate, branched-chain keto acids, and ketoglutarate, its nutritional privation is partly a phenocopy of inborn errors of metabolism, among them maple syrup urine disease. In the present paper, we report metabolic and genomic findings in mice deprived of thiamine. They are similar to the ones we have previously found in biotin deficiency, another ATP generation cofactor. Here we show that thiamine deficiency substantially reduced the energy state in the liver and activated the energy sensor AMP-activated kinase. With this vitamin deficiency, several metabolic parameters changed: blood glucose was diminished and serum lactate was increased, but insulin, triglycerides, and cholesterol, as well as liver glycogen, were reduced. These results indicate a severe change in the energy status of the whole organism. Our findings were associated with modified hepatic levels of the mRNAs of several carbon metabolism genes: a reduction of transcripts for liver glucokinase and fatty acid synthase and augmentation of those for carnitine palmitoyl transferase 1 and phosphoenolpyruvate carboxykinase as markers for glycolysis, fatty acid synthesis, beta-oxidation, and gluconeogenesis, respectively. Glucose tolerance was initially increased, suggesting augmented insulin sensitivity, as we had found in biotin deficiency; however, in the case of thiamine, it was diminished from the 3rd week on, when the deficient animals became undernourished, and paralleled the changes in AKT and mTOR, 2 main proteins in the insulin signaling pathway. Since many of the metabolic and gene expression effects on mice deprived of thiamine are similar to those in biotin deficiency, it may be that they result from a more general impairment of oxidative phosphorylation due to a shortage of ATP generation cofactors. These findings may be relevant to energy-related disorders, among them several inborn errors of metabolism, as well as common energy disorders like obesity, diabetes, and neurodegenerative illnesses.

Keywords:
Thiamine, Biotin, Liver, ATP deficit, AMP-activated kinase, Energy metabolism, Carbon metabolism genes, Glucose tolerance, Insulin sensitivity
1.
Bender DA: Thiamin; in Bender DA (ed): Nutritional Biochemistry of the Vitamins. Cambridge, Cambridge University Press, 1992, pp 128-155.
2.
Nelson DL, Cox MM, Lehninger AL: Lehninger Principles of Biochemistry, ed 4. New York, WH Freeman, 2005.
3.
Abboud MR, Alexander D, Najjar SS: Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr 1985;107:537-541.
4.
Chuang DT, Shih VE, Wynn RM: Maple syrup urine disease (branched-chain ketoaciduria); in Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, et al (eds): The Online Metabolic and Molecular Bases of Inherited Disease. New York, MacGraw-Hill, 2008.
5.
Nutrient requirements of the mouse; in Nutrient Requirements of Laboratory Animals. Washington, National Academies Press, 1995, pp 80-102.
6.
Ochoa-Ruiz E, Díaz-Ruiz R, Hernández-Vázquez Ade J, Ibarra-González I, Ortiz-Plata A, Rembao D, et al: Biotin deprivation impairs mitochondrial structure and function and has implications for inherited metabolic disorders. Mol Genet Metab 2015;116:204-214.
7.
Salvador-Adriano A, Vargas-Chávez S, Hernández-Vázquez Ade J, Ortega-Cuellar D, Tovar AR, Velázquez-Arellano A: Insulin sensitivity is inversely related to cellular energy status, as revealed by biotin deprivation. Am J Physiol Endocrinol Metab 2014;306:E1442-E1448.
8.
Hernández-Vázquez A, Wolf B, Pindolia K, Ortega-Cuellar D, Hernández-González R, Heredia-Antúnez A, et al: Biotinidase knockout mice show cellular energy deficit and altered carbon metabolism gene expression similar to that of nutritional biotin deprivation: clues for the pathogenesis in the human inherited disorder. Mol Genet Metab 2013;110:248-254.
9.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001;25:402-408.
10.
Ortega-Cuellar D, Hernandez-Mendoza A, Moreno-Arriola E, Carvajal-Aguilera K, Perez-Vazquez V, Gonzalez-Alvarez R, et al: Biotin starvation with adequate glucose provision causes paradoxical changes in fuel metabolism gene expression similar in rat (Rattus norvegicus), nematode (Caenorhabditis elegans) and yeast (Saccharomyces cerevisiae). J Nutrigenet Nutrigenomics 2010;3:18-30.
11.
Vetreno RP, Ramos RL, Anzalone S, Savage LM: Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome. Brain Res 2012;1436:178-192.
12.
Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ: Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact 2006;163:94-112.
13.
Hardie DG: Transcription. Targeting the core of transcription. Science 2010;329:1158-1159.
14.
Lee JM, Seo W, Song KH, Chanda D, Kim YD, Kim DK, et al: AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB·CRTC2 complex by orphan nuclear receptor small heterodimer partner. J Biol Chem 2010;285:32182-32191.
15.
Altarejos JY, Montminy M: CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011;12:141-151.
16.
Velazquez-Arellano A, Ortega-Cuellar D, Hernandez-Mendoza A, Moreno-Arriola E: A heuristic model for paradoxical effects of biotin starvation on carbon metabolism genes in the presence of abundant glucose. Mol Genet Metab 2011;102:69-77.
17.
Hernández-Vázquez A, Ochoa-Ruiz E, Ibarra-González I, Ortega-Cuellar D, Salvador-Adriano A, Velázquez-Arellano A: Temporal development of genetic and metabolic effects of biotin deprivation. A search for the optimum time to study a vitamin deficiency. Mol Genet Metab 2012;107:345-351.
18.
Spence JT, Koudelka AP: Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes. J Biol Chem 1984;259:6393-6396.
19.
Moyer MW: Nutrition: vitamins on trial. Nature 2014;510:462-464.
20.
Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, et al (eds): The Online Metabolic and Molecular Bases of Inherited Disease. New York, MacGraw-Hill, 2008.
21.
Labay V, Raz T, Baron D, Mandel H, Williams H, Barrett T, et al: Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 1999;22:300-304.
22.
Fleming JC, Tartaglini E, Steinkamp MP, Schorderet DF, Cohen N, Neufeld EJ: The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet 1999;22:305-308.
23.
Gritli S, Omar S, Tartaglini E, Guannouni S, Fleming JC, Steinkamp MP, et al: A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. Br J Haematol 2001;113:508-513.
24.
WHO, United Nations High Commissioner for Refugees: Thiamine deficiency and its prevention and control in major emergencies. Geneva, WHO, 1999.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.